New therapies for clear cell ovarian carcinoma.
Stewart J, Cunningham N, Banerjee S.
Int J Gynecol Cancer. 2023 Mar 6;33(3):385-393. doi: 10.1136/ijgc-2022-003704.
Ovarian Clear Cell Carcinoma: Genomic Characterization, Pathogenesis and Targeted Therapy.
Xie Y, Kong W, Luo D, Chen S, Zhao X, Zhang HE.
Anticancer Res. 2023 Aug;43(8):3401-3410. doi: 10.21873/anticanres.16515.
Clear cell carcinoma of the ovary: Epidemiology, pathological and biological features, treatment options and clinical outcomes.
Gadducci A, Multinu F, Cosio S, Carinelli S, Ghioni M, Aletti GD.
Gynecol Oncol. 2021 Sep;162(3):741-750. doi: 10.1016/j.ygyno.2021.06.033. Epub 2021 Jul 8.
Translational genomics of ovarian clear cell carcinoma.
Khalique S, Lord CJ, Banerjee S, Natrajan R.
Semin Cancer Biol. 2020 Apr;61:121-131. doi: 10.1016/j.semcancer.2019.10.025. Epub 2019 Nov 4.
Precision medicine for ovarian clear cell carcinoma based on gene alterations.
Kuroda T, Kohno T.
Int J Clin Oncol. 2020 Mar;25(3):419-424. doi: 10.1007/s10147-020-01622-z. Epub 2020 Feb 4.
Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis.
Collins KE, Wang X, Klymenko Y, Davis NB, Martinez MC, Zhang C, So K, Buechlein A, Rusch DB, Creighton CJ, Hawkins SM.
Front Endocrinol (Lausanne). 2023 Aug 9;14:1162786. doi: 10.3389/fendo.2023.1162786. eCollection 2023.
Molecular pathogenesis of ovarian clear cell carcinoma.
Gounaris I, Brenton JD.
Future Oncol. 2015;11(9):1389-405. doi: 10.2217/fon.15.45.
Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for management.
Oda K, Hamanishi J, Matsuo K, Hasegawa K.
Gynecol Oncol. 2018 Nov;151(2):381-389. doi: 10.1016/j.ygyno.2018.09.001. Epub 2018 Sep 12.
Ovarian clear cell carcinoma: an overview of key histopathologic features.
Taylor H, Costigan D.
Int J Gynecol Cancer. 2023 May 1;33(5):843-844. doi: 10.1136/ijgc-2022-004072.
Ovarian clear cell carcinoma meets metabolism; HNF-1beta confers survival benefits through the Warburg effect and ROS reduction.
Mandai M, Amano Y, Yamaguchi K, Matsumura N, Baba T, Konishi I.
Oncotarget. 2015 Oct 13;6(31):30704-14. doi: 10.18632/oncotarget.5228.
